New Drugs, Old Toxicities: Pneumonitis Related to Palbociclib − A Case Report

BACKGROUND: Palbociclib is a specific inhibitor of cyclin-dependent kinases 4 and 6 that is approved for the treatment of advanced or metastatic breast cancer patients. Despite a good toxicity profile in pivotal trials, where asymptomatic neutropenia was the main adverse effect, its wider use in cli...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Breast Care (Basel)
Autors principals: Felip, Eudald, Llobera, Laia, Perez-Mañá, Clara, Quintela, David, Guasch, Ignacio, Margelí, Mireia, Teruel, Iris, Cirauqui, Beatriz, Centeno, Carmen, Romeo, Margarita, Ballana, Ester, Quiroga, Vanesa
Format: Artigo
Idioma:Inglês
Publicat: S. Karger GmbH 2020
Matèries:
Novel Insights from Clinical Practice
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7650093/
https://ncbi.nlm.nih.gov/pubmed/33224001
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000504618
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars